• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Biochemical blood studies in patients with carcinoma of the ovaries during treatment with preparation C-283. II. Behavior of seromucoid and its electrophoretic fractions.

作者信息

Gerber J, Osada J, Jabłoński K, Dobryszycka W

出版信息

Arch Immunol Ther Exp (Warsz). 1972;20(1):139-47.

PMID:4621186
Abstract
摘要

相似文献

1
Biochemical blood studies in patients with carcinoma of the ovaries during treatment with preparation C-283. II. Behavior of seromucoid and its electrophoretic fractions.
Arch Immunol Ther Exp (Warsz). 1972;20(1):139-47.
2
Phase II trial of AMSA in previously treated patients with stage III and IV ovarian cancer.AMSA用于先前接受过治疗的III期和IV期卵巢癌患者的II期试验。
Cancer Treat Rep. 1982 Jul;66(7):1589-90.
3
Biochemical blood studies in patients with carcinoma of the ovaries during treatment with preparation C-283. I. Behavior of serum protein fractions.卵巢癌患者在使用C-283制剂治疗期间的血液生化研究。I. 血清蛋白组分的变化情况
Arch Immunol Ther Exp (Warsz). 1971;19(6):861-8.
4
Biochemical blood studies in patients with ovarian carcinoma treated with C-283. 3. Immunoelectrophoresis of serum proteins.用C-283治疗的卵巢癌患者的血液生化研究。3. 血清蛋白免疫电泳。
Arch Immunol Ther Exp (Warsz). 1972;20(3):367-73.
5
Phase II study of AMSA in patients with advanced ovarian cancer.氨苯吖啶（AMSA）用于晚期卵巢癌患者的II期研究。
Cancer Treat Rep. 1982 May;66(5):1242-3.
6
Behavior of some biochemical components of blood of patients with ovarian carcinoma during Ledakrin treatment.卵巢癌患者在使用立达克林治疗期间血液中某些生化成分的变化
Mater Med Pol. 1976 Jul-Sep;8(3):302-10.
7
[Changes in the serum protein pattern after antiblastic chemotherapy of ovarian carcinoma in advanced stage].
Minerva Ginecol. 1967 Aug 31;19(16):799-801.
8
Treatment of metastatic ovarian carcinoma with amsacrine: a cancer and leukemia group B phase II study.用安吖啶治疗转移性卵巢癌：癌症与白血病B组II期研究。
Cancer Treat Rep. 1984 Nov;68(11):1397-8.
9
Tumor markers in ovarian cancer: a comparison between immunosuppressive acidic protein and alpha 1-acid glycoprotein.
Am J Obstet Gynecol. 1986 May;154(5):1165-6. doi: 10.1016/0002-9378(86)90782-9.
10
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma.
Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1149-50.